Cargando…

Sex difference in appropriate shocks but not mortality during long-term follow-up in patients with implantable cardioverter-defibrillators

AIMS: Implantable cardioverter-defibrillators (ICDs) have been shown to improve survival, although a considerable number of patients never receive therapy. Implantable cardioverter-defibrillators are routinely implanted regardless of sex. There is continuing controversy whether major outcomes differ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Seegers, Joachim, Conen, David, Jung, Klaus, Bergau, Leonard, Dorenkamp, Marc, Lüthje, Lars, Sohns, Christian, Sossalla, Samuel T., Fischer, Thomas H., Hasenfuss, Gerd, Friede, Tim, Zabel, Markus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2016
Materias:	CLINICAL RESEARCH
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4974631/ https://www.ncbi.nlm.nih.gov/pubmed/26622054 http://dx.doi.org/10.1093/europace/euv361

Ejemplares similares

Gender Differences in Appropriate Shocks and Mortality among Patients with Primary Prophylactic Implantable Cardioverter-Defibrillators: Systematic Review and Meta-Analysis
por: Conen, David, et al.
Publicado: (2016)

Remote magnetic versus manual catheter navigation for circumferential pulmonary vein ablation in patients with atrial fibrillation
por: Lüthje, Lars, et al.
Publicado: (2011)

Data on differential multivariable risk prediction of appropriate shock vs. competing mortality
por: Bergau, Leonard, et al.
Publicado: (2018)

Measurement of Left Atrial Pressure is a Good Predictor of Freedom From Atrial Fibrillation
por: Bergau, Leonard, et al.
Publicado: (2014)

Sternal fracture after elective electrical cardioversion of atrial fibrillation
por: Vollmann, Dirk, et al.
Publicado: (2010)

An appropriate shock of the wearable cardioverter-defibrillator in an outpatient setting
por: Kishihara, Jun, et al.
Publicado: (2016)

Subcutaneous Implantable Cardioverter-Defibrillator Shock: Appropriate or Inappropriate?
por: Ip, James E.
Publicado: (2017)

Predictors of mortality and ICD shock therapy in primary prophylactic ICD patients—A systematic review and meta-analysis
por: Bergau, Leonard, et al.
Publicado: (2017)

T-wave loop area from a pre-implant 12-lead ECG is associated with appropriate ICD shocks
por: Seegers, Joachim, et al.
Publicado: (2017)

Sex differences in outcomes of primary prevention implantable cardioverter-defibrillator therapy: combined registry data from eleven European countries
por: Sticherling, Christian, et al.
Publicado: (2018)

Effects of Ranolazine on Torsades de Pointes Tachycardias in a Healthy Isolated Rabbit Heart Model
por: Sossalla, Samuel, et al.
Publicado: (2014)

Incidence of appropriate cardioverter-defibrillator shocks and mortality in patients with implantable cardioverter-defibrillators with ischemic cardiomyopathy versus nonischemic cardiomyopathy at 33-month follow-up
por: Gandhi, Kaushang, et al.
Publicado: (2010)

Insights into permanent pacemaker implantation following TAVR in a real-world cohort
por: Tichelbäcker, Tobias, et al.
Publicado: (2018)

Impact of Moderate to Severe Renal Impairment on Mortality and Appropriate Shocks in Patients with Implantable Cardioverter Defibrillators
por: Alla, Venkata M., et al.
Publicado: (2010)

Clinical effectiveness of primary prevention implantable cardioverter-defibrillators: results of the EU-CERT-ICD controlled multicentre cohort study
por: Zabel, Markus, et al.
Publicado: (2020)

Serial assessment of left atrial deformation in patients undergoing pulmonary vein isolation: a cardiovascular magnetic resonance feasibility study
por: Bergau, Leonard, et al.
Publicado: (2016)

Association of Night-Time Heart Rate With Ventricular Tachyarrhythmias, Appropriate and Inappropriate Implantable Cardioverter-Defibrillator Shocks
por: Sun, Xuerong, et al.
Publicado: (2021)

Management of implantable cardioverter-defibrillator patients with appropriate ICD shocks: A 3-step treatment concept
por: Kleemann, Thomas, et al.
Publicado: (2021)

Predictors of appropriate ICD therapy in patients with implantable cardioverter-defibrillator
por: Dehghani, Mohammad Reza, et al.
Publicado: (2006)

QRS complex and T wave planarity for the prediction of death and appropriate shocks in recipients of prophylactic implantable defibrillators
por: Novotny, T, et al.
Publicado: (2023)

Optimal Medications and Appropriate Implantable Cardioverter-defibrillator Shocks in Aborted Sudden Cardiac Death Due to Coronary Spasm
por: Sueda, Shozo, et al.
Publicado: (2018)

An “UninTENSional” Subcutaneous Implantable Cardioverter-defibrillator Shock
por: Turner, Suzette L., et al.
Publicado: (2018)

Phantom Shocks Associated With a Wearable Cardioverter Defibrillator
por: Delle Donna, Paul, et al.
Publicado: (2021)

Inappropriate subcutaneous implantable cardioverter-defibrillator shocks for bradycardia
por: Chua, Kelvin C.M., et al.
Publicado: (2021)

Fragmented QRS as a Predictor of Appropriate Implantable Cardioverter-defibrillator Therapy
por: Apiyasawat, Sirin, et al.
Publicado: (2014)

Baseline and Dynamic Risk Predictors of Appropriate Implantable Cardioverter Defibrillator Therapy
por: Wu, Katherine C., et al.
Publicado: (2020)

To the Editor— Strategy for revision of subcutaneous implantable cardioverter-defibrillator following inappropriate shock
por: Winter, Joachim, et al.
Publicado: (2019)

Successful defibrillation verification in subcutaneous implantable cardioverter‐defibrillator recipients by low‐energy shocks
por: Biffi, Mauro, et al.
Publicado: (2019)

The Value of the Tei Index in Predicting Implantable Cardioverter Defibrillator Shocks
por: Seyis, Sabri
Publicado: (2018)

Optimal Strategies to Reduce Inappropriate Implantable Cardioverter-defibrillator Shocks
por: Fleeman, Blake E., et al.
Publicado: (2019)

Implantable Cardioverter‐Defibrillator Shocks During COVID‐19 Outbreak
por: Adabag, Selçuk, et al.
Publicado: (2021)

Implantable cardioverter-defibrillator shocks and nonsustained rapid ventricular rhythms
por: Witteveen, H., et al.
Publicado: (2022)

Implantable cardioverter-defibrillator shocks and nonsustained rapid ventricular rhythms
por: Witteveen, H., et al.
Publicado: (2022)

Appropriateness of Prescription and Safety of Wearable Cardioverter Defibrillators: A Single-center Experience
por: Sundhu, Murtaza, et al.
Publicado: (2019)

Appropriate therapy for implantable cardioverter defibrillators used as primary versus secondary prophylaxis
por: Thuraiaiyah, J, et al.
Publicado: (2023)

Rationale, objectives, and design of the EUTrigTreat clinical study: a prospective observational study for arrhythmia risk stratification and assessment of interrelationships among repolarization markers and genotype
por: Seegers, Joachim, et al.
Publicado: (2012)

Impact of signal-averaged electrocardiography findings on appropriate shocks in prophylactic implantable cardioverter defibrillator patients with nonischemic systolic heart failure
por: Nomoto, Michiru, et al.
Publicado: (2022)

The association between defibrillation shock energy and acute cardiac damage in patients with implantable cardioverter defibrillators
por: Ishigaki, Daisuke, et al.
Publicado: (2016)

Implantable cardioverter-defibrillators /
Publicado: (1994)

Loss of capture late after right ventricular pacing lead revision: what is the mechanism?
por: Seegers, Joachim, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_a11l1f3qitjougcd1b01004bta